Avidity Biosciences Enrolls Patients in the MARINA™ Open-Label Extension Study
Go back to Avidity Biosciences Enrolls Patients in the MARINA™ Open-Label Extension Study| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 12.29 +0.53 (4.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.76 | 52 Week High | $22.80 | |||
| Open | $11.73 | 52 Week Low | $4.12 | |||
| Day High | $12.35 | P/E | N/A | |||
| Day Low | $11.61 | EPS | $0.00 | |||
| Volume | 181,959 | |||||
